Quarterly Consolidated Statement Of Cash Flows

SanBio Company Limited - Filing #7266375

Concept As at
2025-01-31
2024-02-01 to
2025-01-31
2024-02-01 to
2025-01-31
As at
2024-01-31
2023-02-01 to
2024-01-31
2023-02-01 to
2024-01-31
As at
2023-01-31
Quarterly consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss) before income taxes
-3,673,586,000 JPY
-3,010,666,000 JPY
-4,031,968,000 JPY
-2,542,135,000 JPY
Depreciation
9,368,000 JPY
14,504,000 JPY
Interest and dividend income
-2,399,000 JPY
-2,465,000 JPY
Interest expenses
8,315,000 JPY
10,548,000 JPY
Foreign exchange losses (gains)
-625,868,000 JPY
-1,651,512,000 JPY
Other, net
-24,074,000 JPY
83,206,000 JPY
Subtotal
-3,580,968,000 JPY
-4,756,778,000 JPY
Interest and dividends received
2,399,000 JPY
2,465,000 JPY
Interest paid
-8,317,000 JPY
-10,557,000 JPY
Income taxes paid
-16,220,000 JPY
-783,000 JPY
Net cash provided by (used in) operating activities
-3,603,106,000 JPY
-4,765,654,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-4,891,000 JPY
-11,078,000 JPY
Proceeds from sale of property, plant and equipment
864,000 JPY
35,941,000 JPY
Net cash provided by (used in) investing activities
-4,267,000 JPY
-19,028,000 JPY
Cash flows from financing activities
Repayments of long-term borrowings
-268,000,000 JPY
-268,000,000 JPY
Proceeds from issuance of shares
1,891,824,000 JPY
JPY
Other, net
-194,000 JPY
-34,000 JPY
Net cash provided by (used in) financing activities
2,091,005,000 JPY
2,370,532,000 JPY
Effect of exchange rate change on cash and cash equivalents
-20,019,000 JPY
128,472,000 JPY
Net increase (decrease) in cash and cash equivalents
-1,536,388,000 JPY
-2,285,678,000 JPY
Cash and cash equivalents
2,853,132,000 JPY
4,389,520,000 JPY
6,675,198,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.